Zydus Cadila launches COVID-19 drug Remdesivir in India - watsupptoday.com
Zydus Cadila launches COVID-19 drug Remdesivir in India
Posted 13 Aug 2020 05:05 PM

Image Source: India TV News

Agencies:

Drug firm Zydus Cadila today said it has launched Remdesivir under the brand name Remdac, used to treat patients suffering from severe symptoms of COVID-19 in the Indian market.

Priced at Rs 2,800 per 100 mg vial, Remdac is the most economical Remdesivir brand in India, Zydus Cadila said in a regulatory filing.

The Company said the drug will be made available across India through the group�s strong distribution chain reaching out to Government and Private hospitals treating COVID-19 patients.

Remdac is the most affordable drug as we would like to enable patients to have access to this critical drug in the treatment of COVID-19, Cadila Healthcare Managing Director Dr. Sharvil Patel said.

Leave a comment: (Your email will not be published)